Varian Medical Systems Inc

Varian Medical Systems — Corporate Update (January 2018)

33 slides from Varian Medical Systems's corporate update, Jan 11, 2018

  1. Slide 1: New revenue accounting standard (ASC 606) and FY18 guidance

    New revenue accounting standard (ASC 606) and FY18 guidance January 11, 2018 Gary E. Bischoping Jr., Chief Financial Officer Magnus Momsen, Chief Accounting Officer J. Michael Bruff, Vice President Investor Relations

  2. Slide 2: Forward-Looking Statements

    FORWARD - LOOKING STATEMENTS Except for historical information, this presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 . Statements concerning industry outlook, including growth drivers, future trends in cancer incidence and

  3. Slide 3: Agenda

    New revenue accounting standard (ASC 606) Change in service orders policy Fiscal years 2016 and 2017 Adjusted Key Earnings Financial Metrics FY18 guidance (translation) Q&A Appendix: Financial Metrics 3 Agenda

  4. Slide 4: New revenue accounting standard (ASC 606)

    New revenue accounting standard (ASC 606) 4

  5. Slide 5: New revenue accounting standard (ASC 606)

    New revenue accounting standard (ASC 606) Step 1 Identify the contracts with the customer Step 2 Identify the separate performance obligations in the contract Step 3 Determine the transaction price Step 5 Recognize revenue when (or as) the entity satisfies a performance obligation 5 Step 4 Allocate

  6. Slide 6: What does not change, what changes, what are the impacts

    What does not change? • Economics of the overall business; cash and net operating cash flows • Operating expenses, including commissions expense • Non - GAAP reconciling items • Customer billings • Customer relationships What changes? • Revenues and gross margin related to contingent payments, softw

  7. Slide 7: Contingent Payment Example Financial Impact

    Contingent Payment Example Financial Impact Both examples have a hardware sale for $2,000, of which $1,900 is the fair value of the hardware and $100 is the fair value of the installation service; hardware cost of $1,000 and installation cost of $75. Example 1 • Payment terms 80% on machine delivery

  8. Slide 8: VSOE Example Financial Impact

    VSOE Example Financial Impact 8 Example Three software products (Product A, B & C) sold together with a fair value of $250 each and cost of $50 each Software Product A & B have VSOE, Product C does not Software Products A and B are delivered in P1 and Product C is delivered in P2 What changed? VSOE

  9. Slide 9: Software Extended Payment Example Financial Impact

    Software Extended Payment Example Financial Impact 9 Example Software system sold for $1,000, cost of $200, with payment terms as follows: • $250k due on acceptance • $250K due 1 year after acceptance • $250K due 2 years after acceptance • $250K due 3 years after acceptance What changed? Payment ter

  10. Slide 10: Other Performance Obligations Example Financial Impact

    Other Performance Obligations Example Financial Impact 10 Example Equipment sold for $2,000 which includes service - type warranties with a fair value of $50 and training with a fair value of $40 • Cost of the equipment $1,100 (excluding service - type warranties and training) • Cost of service - ty

  11. Slide 11: FY17 and FY16 Revenue prior to new revenue standard

    $900 $1,200 $1,500 $1,800 $2,100 $2,400 $2,700 FY17 Restated to prior years Recognized in current year Other, net FY17 VSOE Contingent Revenue (Terms) $1,500 $1,800 $2,100 $2,400 $2,700 FY16 Restated to prior years Recognized in current year Other, net FY16 VSOE Contingent Revenue (Terms) FY17 and F

  12. Slide 12: FY17 and FY16 Gross Margin prior to new revenue standard

    $0 $200 $400 $600 $800 $1,000 $1,200 FY17 Restated to prior years Recognized in current year Other, net FY17 VSOE Contingent Revenue (Terms) $0 $200 $400 $600 $800 $1,000 $1,200 FY16 Restated to prior years Recognized in current year Other, net FY16 VSOE Contingent Revenue (Terms) FY17 and FY16 Gros

  13. Slide 13: Change in Service Orders Policy

    Change in Service Orders Policy

  14. Slide 14: Total Varian: Change in Gross Orders Policy Impact to Gross Orders and Backlog

    Total Varian : Change in Gross Orders Policy Impact to Gross Orders and Backlog Non - GAAP Investor Metrics 14 Total Varian ($M) 2015 2016 2017 Gross orders Prior orders $3,017 $2,829 $3,135 Y/Y -6% 11% Change in deferred revenue ($42) ($22) ($59) New orders $2,975 $2,807 $3,076 Y/Y -6% 10% Backlog

  15. Slide 15: Oncology: Change in Gross Orders Policy Impact to Gross Orders and Backlog

    Oncology : Change in Gross Orders Policy Impact to Gross Orders and Backlog Non - GAAP Investor Metrics 15 Oncology business unit ($M) 2015 2016 2017 Gross orders Prior orders $2,700 $2,724 $2,906 Y/Y 1% 7% Change in deferred revenue ($45) ($22) ($59) New orders $2,655 $2,702 $2,847 Y/Y 2% 5% Backlo

  16. Slide 16: Fiscal Years 2016 and 2017 Adjusted Key Earnings Financial Metrics

    Fiscal Years 2016 and 2017 Adjusted Key Earnings Financial Metrics

  17. Slide 17: Adjusted financial summary: FY17 growth

    Adjusted financial summary: FY17 growth 17 1 Gross orders and backlog reflect the net impact of the change in service order policy and ASC 606 2 Reflects ‘from continuing operations attributable to Varian’ Note: The discussion of Non - GAAP financial disclosures and the reconciliation of GAAP to Non

  18. Slide 18: Adjusted GAAP financial summary: FY17 by quarter

    Adjusted GAAP financial summary: FY17 by quarter 18 1 Gross orders and backlog reflect the net impact of the change in service order policy and ASC 606 2 Reflects ‘from continuing operations attributable to Varian’ Note: The discussion of Non - GAAP financial disclosures and the reconciliation of GA

  19. Slide 19: FY18 Guidance (Translation)

    FY18 Guidance (Translation)

  20. Slide 20: Varian consolidated FY18 Guidance

    Varian consolidated FY18 Guidance (1) These values are presented on a non - GAAP basis. We have not provided a reconciliation of non - GAAP guidance measures to the corre sponding GAAP measures on a forward - looking basis due to potential significant variability and limited visibility of the exclud

  21. Slide 21: Q&A

    Q&A

  22. Slide 22: Appendix: Financial Metrics

    Appendix: Financial Metrics

  23. Slide 23: Non-GAAP disclosure

    Non - GAAP disclosure 23 Discussion of Non - GAAP Financial Measures This presentation includes the following non - GAAP financial measures derived from our Condensed Consolidated Statements of Earnings : non - GAAP operating earnings, non - GAAP net earnings and non - GAAP net earnings per diluted

  24. Slide 24: Adjusted GAAP to non-GAAP reconciliation

    Adjusted GAAP to non - GAAP reconciliation 24 (1) Includes $1 million, $1 million, $1 million, $1 million and $5 million respectively, in cost of revenues for the periods pres ent ed. (2) Other includes acquisition - related expenses and benefits. (3) Excludes immaterial net earnings (loss) from con

  25. Slide 25: Varian consolidated (GAAP) Key P&L Financial Metrics

    Varian consolidated (GAAP) Key P&L Financial Metrics 25 Note: Unless noted otherwise, all ‘Orders’ reflects Gross Orders, all growth rates are in dollars, and year on year, and all numbers reflect continuing operations. $M Full Year Y/Y Full Year Y/Y Gross Orders $3,135 11% $3,076 10% Revenues $2,66

  26. Slide 26: Varian consolidated (non-GAAP) Key P&L Financial Metrics

    Varian consolidated (non - GAAP) Key P&L Financial Metrics Note: Unless noted otherwise, all ‘Orders’ reflects Gross Orders, all growth rates are in dollars, and year on year, and all numbers reflect continuing operations. 26 $M Full Year Y/Y Full Year Y/Y Gross Orders $3,135 11% $3,076 10% Revenues

  27. Slide 27: Varian consolidated Key Balance Sheet and Cash Flow Metrics

    Varian consolidated Key Balance Sheet and Cash Flow Metrics • No change due to adoption of ASC 606 VARIAN FISCAL 2017 $M 1Q 2Q 3Q 4Q Full Year Cash & Cash Equivalents 1 $815 $706 $658 $716 - Cash Flows from Operations 2 $82 $32 $155 $130 $399 Y/Y % 6.0% 1.0% 63.0% - 15.0% 12.0% Total Debt $607 $547

  28. Slide 28: Oncology business unit Key Financial Metrics

    Oncology business unit Key Financial Metrics 28 Note: Unless noted otherwise, all ‘Orders’ reflects Gross Orders, all growth rates are in dollars, and year on year, and all numbers reflect continuing operations. 1 Business unit operating earnings includes an allocation of corporate costs based on re

  29. Slide 29: Particle Therapy business unit Key Financial Metrics

    Particle Therapy business unit Key Financial Metrics VARIAN FISCAL 2017 $M Full Year Y/Y Gross Orders $229 120% Revenues $182 12% Product $172 13% Svcs $10 4% GM $16 - 36% % of Rev 8.8% - 661 bps Operating Earnings 1 - $96 - 115% % of Rev - 52.5% - 2,507 bps 29 Note: Unless noted otherwise, all ‘Ord

  30. Slide 30: Total revenues by sales classification

    Total revenues by sales classification 30 $M 1Q 2Q 3Q 4Q FY17 Product revenues $309 $365 $325 $403 $1,402 Y/Y -4% Service revenues $292 $298 $308 $319 $1,217 Y/Y 7% Total revenues $601 $663 $633 $722 $2,619 Y/Y 1% Product as a percentage of total revenues 51% 55% 51% 56% 54% Service as a percentage

  31. Slide 31: Total Oncology revenues by sales classification

    Total Oncology revenues by sales classification 31 $M 1Q 2Q 3Q 4Q FY17 Product revenues $282 $336 $258 $354 $1,230 Y/Y -5% Service revenues $289 $296 $306 $316 $1,207 Y/Y 7% Total revenues $571 $632 $564 $670 $2,437 Y/Y 0% Product as a percentage of Oncology Systems revenues 49% 53% 46% 53% 50% Serv

  32. Slide 32: Total Particle Therapy revenues by sales classification

    Total Particle Therapy revenues by sales classification 32 $M 1Q 2Q 3Q 4Q FY17 Product revenues $27 $29 $67 $49 $172 Y/Y 13% Service revenues $3 $2 $2 $3 $10 Y/Y 4% Total revenues $30 $31 $69 $52 $182 Y/Y 12% VPT revenues as a percentage of total revenues 5% 5% 11% 7% 7%

  33. Slide 33: Varian

    varian

Varian Medical Systems — Corporate Update (January 2018) on 6ix